Syndax Pharmaceuticals Inc. logo

Syndax Pharmaceuticals Inc.

SNDX | NASDAQ
Chart Builder DCF Calculator
$18.03
-$0.04 (-0.22%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
134.93M 154.08M 295.39M 74.36M 221.97M 115.24M
Short-Term Investments
278.76M 428.83M 282.19M 410.04M 224.87M 177.82M
Long-Term Investments
n/a 119.52M 29.83M 5.47M n/a n/a
Other Long-Term Assets
102K 217K 680K 922K n/a 1.27M
Receivables
70.29M 13.87M 1.23M 4.06M 429K 175K
Inventory
32.75M 366K n/a n/a n/a n/a
Other Current Assets
1.22M -2.02M 63K 117K 265K 456K
Total Current Assets
528.08M 603.06M 580.88M 489.79M 448.4M 298.86M
Property-Plant & Equipment
1.52M 2.02M 1.5M 1.06M 1.26M 482K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.63M 121.76M 32M 7.45M 1.26M 1.75M
Total Assets
529.71M 724.82M 612.88M 497.24M 449.66M 300.61M
Account Payables
16.58M 11.63M 9.96M 4.35M 5.67M 3.51M
Deferred Revenue
n/a n/a n/a n/a n/a 1.52M
Short-Term Debt
n/a 12.12M n/a n/a n/a 2.29M
Other Current Liabilities
103.06M 15.75M 35.92M 6.55M 6.23M 3.74M
Total Current Liabilities
120.12M 103.55M 58.1M 29.07M 20.68M 18.87M
Long-Term Debt
344.96M 331.57M n/a n/a 19.9M 17.83M
Other Long-Term Liabilities
-1.05M n/a n/a n/a n/a 1K
Total Long-Term Liabilities
344.96M 333.14M 588K 722K 20.61M 29.55M
Total Liabilities
465.08M 436.69M 58.68M 29.79M 41.29M 48.43M
Total Debt
346.48M 345.74M 1.64M 1.16M 20.97M 20.54M
Book Value
64.63M 288.12M 554.2M 467.45M 408.37M 252.19M
Book Value Per Share
0.75 3.37 7.88 7.69 7.84 6.11
Common Stock
9K 9K 8K 7K 6K 5K
Retained Earnings
-1.51B -1.22B -902.4M -693.04M -543.7M -568.63M
Comprehensive Income
452K 163K 218K -806K 45K -4K
Shareholders Equity
64.63M 288.12M 554.2M 467.45M 408.37M 252.19M
Total Investments
278.76M 548.35M 312.02M 415.51M 224.87M 177.82M

© 2026 bestshares.com. All rights reserved.